Ayurcann Holdings Corp. (OTCPK: AYUR.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Ayurcann Holdings Corp. (OTCPK: AYUR.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $58.41K.
trading between 0.00 and 0.03.
Tweenvest scores Ayurcann Holdings Corp. across four factors: quality 44/100, value 55/100, growth 100/100. Its strongest factor is growth.
AYUR.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $58.41K
- Revenue (TTM)
- $22.46M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 2.72
- 52-week high
- $0.03
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 194.70M
- Employees
- —
- Next earnings
- —
About Ayurcann Holdings Corp.
Ayurcann Holdings Corp. provides comprehensive post-harvest outsourcing solutions for licensed cannabis producers throughout Canada. Its end-to-end services encompass various stages, including raw material extraction and refinement, bulk distillate oil sales, product formulation, and white-label manufacturing. The company further supports clients with fulfillment, distribution, custom packaging development, and inventory control. In addition to these business-to-business services, Ayurcann produces and markets its own line of medicinal cannabis products, such as tinctures, vapes, and topicals. It also manages the Ayurcann marketplace, an e-commerce platform dedicated to medical cannabis consumers. The company was founded in 2018 and is based in Pickering, Canada.
- Listed since
- Feb 14, 2011
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.